IL29570A - Preparations for the treatment of leukoma containing a history of 5, 01 - Epoxy - H5 - Dibenzo] a, d [Cyclohapthen - Google Patents

Preparations for the treatment of leukoma containing a history of 5, 01 - Epoxy - H5 - Dibenzo] a, d [Cyclohapthen

Info

Publication number
IL29570A
IL29570A IL29570A IL2957068A IL29570A IL 29570 A IL29570 A IL 29570A IL 29570 A IL29570 A IL 29570A IL 2957068 A IL2957068 A IL 2957068A IL 29570 A IL29570 A IL 29570A
Authority
IL
Israel
Prior art keywords
dibenzo
epoxy
compositions
treatment
dihydro
Prior art date
Application number
IL29570A
Other languages
English (en)
Hebrew (he)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL29570A publication Critical patent/IL29570A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
IL29570A 1967-03-16 1968-03-04 Preparations for the treatment of leukoma containing a history of 5, 01 - Epoxy - H5 - Dibenzo] a, d [Cyclohapthen IL29570A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62354067A 1967-03-16 1967-03-16

Publications (1)

Publication Number Publication Date
IL29570A true IL29570A (en) 1971-07-28

Family

ID=24498471

Family Applications (1)

Application Number Title Priority Date Filing Date
IL29570A IL29570A (en) 1967-03-16 1968-03-04 Preparations for the treatment of leukoma containing a history of 5, 01 - Epoxy - H5 - Dibenzo] a, d [Cyclohapthen

Country Status (8)

Country Link
US (1) US3467756A (fr)
BE (1) BE712259A (fr)
DE (1) DE1667898A1 (fr)
FR (1) FR7841M (fr)
GB (1) GB1174882A (fr)
IE (1) IE31971B1 (fr)
IL (1) IL29570A (fr)
NL (1) NL6802823A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716952A (en) * 1992-03-18 1998-02-10 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists
US6077839A (en) 1992-03-19 2000-06-20 Allergan Sales, Inc. Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (GABA) agonists
WO1995034302A2 (fr) * 1994-06-16 1995-12-21 Allergan Procede utile pour reduire la pression intraoculaire dans l'×il mammalien a l'aide de composes chelatant le calcium
US6350780B1 (en) 1995-07-28 2002-02-26 Allergan Sales, Inc. Methods and compositions for drug delivery

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3264342A (en) * 1963-05-24 1966-08-02 Geigy Chem Corp Derivatives of 5h-dibenzo[a, d] cycloheptene
US3336340A (en) * 1963-11-29 1967-08-15 Rohm & Haas Benzopyrans and process for the preparation thereof

Also Published As

Publication number Publication date
GB1174882A (en) 1969-12-17
BE712259A (fr) 1968-09-16
NL6802823A (fr) 1968-09-17
FR7841M (fr) 1970-05-25
DE1667898A1 (de) 1971-07-22
US3467756A (en) 1969-09-16
IE31971L (en) 1968-09-16
IE31971B1 (en) 1973-03-07

Similar Documents

Publication Publication Date Title
EP0752847B1 (fr) Composition ophtalmique a viscosite reduite
EP0389995B1 (fr) Dérivés de l'isoquinoléine pour le traitement de glaucome ou de l'hypertension oculaire
US20100041671A1 (en) Methods for treating glaucoma
JPS62178514A (ja) 眼局所投与用眼圧降下剤
CZ286496A3 (en) Eye preparation containing hydrophilic polymer responsive to ions and inorganic salt in a ratio, at which it exhibits low viscosity
JPS6322021A (ja) 眼圧制御剤
EP0338507A2 (fr) Utilisation du mabutérol et de dérivés semblables pour normaliser la tension intra-oculaire
US5554367A (en) Compositions for treatment of glaucoma
IL29570A (en) Preparations for the treatment of leukoma containing a history of 5, 01 - Epoxy - H5 - Dibenzo] a, d [Cyclohapthen
JPH10324640A (ja) 炭酸脱水酵素阻害剤およびβ遮断剤を含有する局所用抗緑内障組成物
JP3094233B2 (ja) (s)−チモロール半水和物を含有する局所眼科治療用組成物及びその製造方法
US4623664A (en) Oil suspended phenylephrine
GB2100599A (en) Pharmaceutical preparation for treating glaucoma and ocular hypertension
US3920824A (en) Stable ophthalmic formulation
US3644647A (en) Treatment of glaucoma employing 5-(3-methylaminopropyl - 5h - dibenzo(a b) cycloheptene
EP1137407B1 (fr) formulation ophtalmique comprenant un beta-bloquant et du carbopol
EP0728480A1 (fr) Utilisation d'ifenprodil pour le traitement de la pression intraoculaire élevée
JPH03106816A (ja) 緑内障治療用点眼剤
EP4309675A1 (fr) Promédicament de célécoxib, son procédé de préparation et son application
KR20210143254A (ko) 마취 조성물 및 안구의 마취 방법
US3888985A (en) Method and composition for lowering intraocular pressure
CA2929965C (fr) Methode et composition permettant de traiter le glaucome
EP0589020A4 (en) Verapamil hcl formulation and other ophthalmic solutions with buffer system for ocular administration
KR20230004582A (ko) 에피나스틴 또는 그 염을 함유하는 수성 조성물
JPS5833202B2 (ja) ガンカヨウシヨホウノ アンテイカホウ